2019
DOI: 10.1016/j.biopha.2018.10.182
|View full text |Cite
|
Sign up to set email alerts
|

Piperlongumine, a piper alkaloid targets Ras/PI3K/Akt/mTOR signaling axis to inhibit tumor cell growth and proliferation in DMH/DSS induced experimental colon cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

5
46
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 77 publications
(51 citation statements)
references
References 40 publications
5
46
0
Order By: Relevance
“…Oxaliplatin in combination with piperlongumine, a natural product constituent of the fruit of the Long pepper (Piper longum), has been shown to act synergically and induce CRC cell apoptosis via mitochondrial dysfunction and endoplasmic reticulum stress [128]. The mode of piperlongumine action in experimental colon cancer has recently been updated [129]. Our results showed that co-treatment of CRC cells with 5FU and Ganoderma Lucidum induces oxidative DNA damage in CRC cell lines.…”
Section: Possible Utilization Of Oxidative Dna Damage In Colorectal Cmentioning
confidence: 67%
“…Oxaliplatin in combination with piperlongumine, a natural product constituent of the fruit of the Long pepper (Piper longum), has been shown to act synergically and induce CRC cell apoptosis via mitochondrial dysfunction and endoplasmic reticulum stress [128]. The mode of piperlongumine action in experimental colon cancer has recently been updated [129]. Our results showed that co-treatment of CRC cells with 5FU and Ganoderma Lucidum induces oxidative DNA damage in CRC cell lines.…”
Section: Possible Utilization Of Oxidative Dna Damage In Colorectal Cmentioning
confidence: 67%
“…It might be because AOM administration was a week ahead of PL treatment, and PL can affect DSS-induced inflammation, but not AOM-induced mutagenesis and tumorigenesis. Similarly, a recent report has shown that PL could suppress tumor cell growth and proliferation in DMH/ DSS-induced experimental colon cancer by targeting Ras/PI3K/ Akt/mTOR signaling axis (Kumar and Agnihotri, 2019). PLinduced Cyclin D1 downregulation and tumor suppression in colorectal cancer cells by suppression of ERKs/Akt-mediated c-Fos expression (Gao et al, 2020).…”
Section: Discussionmentioning
confidence: 95%
“…Our data showed that SLBZ-AP Many researchers confirmed that PI3K/Akt/mTOR signaling pathway is related to a few biological activities to affect cell proliferation, survival, and migration [7,8], especially to stimulate proliferation, survival, invasion/metastasis, and metabolic reprogramming and suppress autophagy, which is involved in possible mechanisms of oncogenic transformation [9]. PI3K/Akt/mTOR signaling pathway is commonly activated and suppression of its activation may inhibit cells proliferation and metastasis in cancers of the lung [10,11,50], colorectal [51,52], esophagus [53], breast [54][55][56], liver [57,58], and kidney [59,60], which has been considered a promising therapeutic target. Whether the PI3K/Akt/mTOR signaling pathway involved in SLBZ-AP affects BMLC was further explored in our study, results of which indicated that the mRNA and protein expression of AKT, mTOR, P70S6, and VEGF as well as protein expression of p-AKT, p-mTOR, p-P70S6, and VEGF was significantly increased in the marrow of tibia from BMLC mice.…”
Section: Discussionmentioning
confidence: 99%